In April 2015, Project HOPE and AstraZeneca inaugurated an exciting multi-year partnership, with the launch of two initiatives in China – one focusing on chronic respiratory diseases and another on diabetes. AstraZeneca is a global, innovation-driven biopharmaceutical corporation, focusing on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. With a long-standing commitment to improving the health of people around the world, AstraZeneca operates in more than 100 countries, and its innovative medicines are used by millions of patients in need.
With the aim of improving the lives of the millions of people suffering from chronic respiratory diseases in China, Project HOPE and AstraZeneca are launching the China Alliance of Respiratory Diseases Prevention and Treatment (CARD). The CARD program will increase awareness of respiratory diseases among policy makers and key stakeholders, conduct training for healthcare professionals in disease prevention and treatment, begin to integrate lung function screening into primary care services, and establish online training modules for primary health care providers outside of China’s major urban areas. With a commitment to Chinese patients, AstraZeneca China lends its legacy of scientific knowledge and research capabilities to CARD, increasing HOPE’s capacity to address the burden of chronic respiratory diseases in China.
Project HOPE and AstraZeneca are also working together to provide quality diabetes education for professionals, and improve services and care for people living with diabetes in China. The program will help fill gaps in diabetes education and long-term care, further strengthening both organizations’ commitment and capabilities in diabetes prevention, particularly in high-risk countries such as China. By providing comprehensive training to better equip general practitioners and nurses to care for diabetes patients, in addition to screening at-risk individuals, AstraZeneca and HOPE will be able to improve the health and well-being of people living with diabetes.
In addition to these two programs in China, AstraZeneca and Project HOPE are exploring activities aimed at preventing diabetes and improving the health and wellbeing of those living with diabetes, particularly during the month of Ramadan, in the United Arab Emirates. In Mexico, AstraZeneca and Project HOPE are currently partnering on a health needs assessment to survey the gaps in diabetes health care in specific areas of the country.
AstraZeneca continues to be a generous and valued partner of Project HOPE through these activities, as well as support for our overall global health programs around the world. With partners like AstraZeneca, Project HOPE is able to continue improving the health and wellbeing of those in need around the world – and we are grateful for its dedication and commitment to HOPE.
Get news from the field and updates on how your donations are being put to work.
Read and share stories about Project HOPE with your personal network.